Dmitry Balyasny’s Medtronic MDT Stock Holding History

Dmitry Balyasny’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.83M	Sell	100,100 -10,800	-10%	-$871K	0.01%	1172
2026 Q1	$9.61M	Sell	110,900 -57,000	-34%	-$5.46M	0.01%	1052
2025 Q4	$16.1M	Sell	167,900 -32,800	-16%	-$3.19M	0.02%	827
2025 Q3	$19.1M	Buy	200,700 +104,100	+108%	+$9.57M	0.02%	737
2025 Q2	$8.42M	Buy	96,600 +42,900	+80%	+$3.64M	0.01%	1042
2025 Q1	$4.83M	Sell	53,700 -32,200	-37%	-$2.88M	0.01%	1260
2024 Q4	$6.86M	Buy	85,900 +41,300	+93%	+$3.58M	0.01%	1124
2024 Q3	$4.02M	Buy	+44,600	New	+$3.75M	0.01%	1360
2024 Q2	–	Sell	-96,700	Closed	-$8.43M	–	2900
2024 Q1	$8.43M	Buy	96,700 +93,700	+3,123%	+$8M	0.01%	1006
2023 Q4	$247K	Buy	+3,000	New	+$229K	﹤0.01%	2242
2021 Q3	–	Sell	-6,700	Closed	-$832K	–	2235
2021 Q2	$832K	Buy	+6,700	New	+$841K	﹤0.01%	1371
2017 Q4	–	Sell	-550,000	Closed	-$42.8M	–	2205
2017 Q3	$42.8M	Buy	+550,000	New	+$45.7M	0.17%	167
2016 Q2	–	Sell	-150,000	Closed	-$11.3M	–	1339
2016 Q1	$11.3M	Buy	+150,000	New	+$11.3M	0.07%	366

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Dmitry Balyasny's MDT Position: Q2 2026 in Review

Dmitry Balyasny increased its Medtronic (MDT) stake by 2,346% in Q2 2026, buying an estimated $76.3M and bringing the position to 986,367 shares worth $77.2M. The position accounts for 0.1% of the portfolio, ranked #246.

Dmitry Balyasny first reported a position in MDT in Q2 2013 and has held it in 40 quarters since. The position peaked at $220M in Q2 2025. 2,126 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Dmitry Balyasny held 986,367 shares of Medtronic worth $77.2M as of Q2 2026.
Dmitry Balyasny bought 946,039 Medtronic shares in Q2 2026, an estimated $76.3M.
Medtronic made up 0.1% of Dmitry Balyasny's portfolio in Q2 2026, its #246 holding.
Dmitry Balyasny first reported a position in Medtronic in Q2 2013 and has held it in 40 quarters since.
Dmitry Balyasny's Medtronic position peaked at $220M in Q2 2025.
2,126 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.